AGEMED, within Bolivia's Ministry of Health and Sports, operates the national pharmacovigilance framework and medicine-safety reporting infrastructure.
Core official resources
- AGEMED — national medicine authority, safety communications and pharmacovigilance information.
- MISA public reporting — electronic forms for suspected adverse reactions, therapeutic/pharmaceutical failures and vaccine-related events.
Practical use
The public MISA interface includes Form 020 for suspected adverse drug reactions, Form 029 for therapeutic or pharmaceutical failures and Form 030 for vaccine-related events. Current AGEMED safety communications direct reporters to this electronic route for suspected adverse reactions.